Heart disease (Hagerstown, Md.)最新文献

筛选
英文 中文
Pharmacotherapy of diabetes mellitus: implications for the prevention and treatment of cardiovascular disease. 糖尿病的药物治疗:对预防和治疗心血管疾病的意义。
Heart disease (Hagerstown, Md.) Pub Date : 2003-01-01 DOI: 10.1097/01.HDX.0000050411.62103.F5
Enzo Ragucci, Joel Zonszein, William H Frishman
{"title":"Pharmacotherapy of diabetes mellitus: implications for the prevention and treatment of cardiovascular disease.","authors":"Enzo Ragucci,&nbsp;Joel Zonszein,&nbsp;William H Frishman","doi":"10.1097/01.HDX.0000050411.62103.F5","DOIUrl":"https://doi.org/10.1097/01.HDX.0000050411.62103.F5","url":null,"abstract":"<p><p>Diabetes mellitus in adults is associated with an increased risk of premature vascular disease and a higher mortality rate. The presence of other risk factors, often seen in diabetic patients, such as systemic hypertension, augments the rate of vascular diseases. Evidence is growing that tight control of hyperglycemia using insulin and/or oral hypoglycemic agents will modify this risk. More aggressive control of concomitant hypertension and/or hyperlipidemia is also required. Diabetic patients who have myocardial infarctions do worse than nondiabetic patients. Various strategies to improve outcomes include the use of tight blood glucose control, and various coronary interventions are currently under clinical study.</p>","PeriodicalId":83724,"journal":{"name":"Heart disease (Hagerstown, Md.)","volume":"5 1","pages":"18-33"},"PeriodicalIF":0.0,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/01.HDX.0000050411.62103.F5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22215691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Calcium Antagonists in Clinical Medicine, 3rd edition. 临床医学中的钙拮抗剂,第三版。
Heart disease (Hagerstown, Md.) Pub Date : 2003-01-01 DOI: 10.1097/01.HDX.0000050405.10739.7B
R. Kay
{"title":"Calcium Antagonists in Clinical Medicine, 3rd edition.","authors":"R. Kay","doi":"10.1097/01.HDX.0000050405.10739.7B","DOIUrl":"https://doi.org/10.1097/01.HDX.0000050405.10739.7B","url":null,"abstract":"","PeriodicalId":83724,"journal":{"name":"Heart disease (Hagerstown, Md.)","volume":"5 1","pages":"79"},"PeriodicalIF":0.0,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/01.HDX.0000050405.10739.7B","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"61660256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anemia and hypocholesterolemia. 贫血和低胆固醇血症。
Heart disease (Hagerstown, Md.) Pub Date : 2003-01-01 DOI: 10.1097/01.HDX.0000050420.79522.09
Bulent Atac, Driola Brahaj, William H Frishman, Robert Lerner
{"title":"Anemia and hypocholesterolemia.","authors":"Bulent Atac,&nbsp;Driola Brahaj,&nbsp;William H Frishman,&nbsp;Robert Lerner","doi":"10.1097/01.HDX.0000050420.79522.09","DOIUrl":"https://doi.org/10.1097/01.HDX.0000050420.79522.09","url":null,"abstract":"<p><p>The authors reviewed the available data on the relationship between hypocholesterolemia and anemia with various etiologies. The data were collected from sources identified by a MEDLINE search of English-language literature published between 1966 and 2001 and bibliographies of relevant articles. The study selection included primary research articles, metaanalyses, and abstracts concerning the relation between hypocholesterolemia and anemia. Textbooks, meeting proceedings, and reference lists were also searched. Despite differences in study design, a relation was found between hematocrit and serum cholesterol levels and between hemoglobin and cholesterol levels. Further studies are required to determine the exact etiology and clinical significance of these findings.</p>","PeriodicalId":83724,"journal":{"name":"Heart disease (Hagerstown, Md.)","volume":"5 1","pages":"65-71"},"PeriodicalIF":0.0,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/01.HDX.0000050420.79522.09","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22215695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
Should salt restriction be advised for every patient with hypertension? 是否应该建议每个高血压患者限制食盐摄入?
Heart disease (Hagerstown, Md.) Pub Date : 2002-11-01 DOI: 10.1097/00132580-200211000-00010
Krishan L Gupta, Veena Gupta
{"title":"Should salt restriction be advised for every patient with hypertension?","authors":"Krishan L Gupta,&nbsp;Veena Gupta","doi":"10.1097/00132580-200211000-00010","DOIUrl":"https://doi.org/10.1097/00132580-200211000-00010","url":null,"abstract":"","PeriodicalId":83724,"journal":{"name":"Heart disease (Hagerstown, Md.)","volume":"4 6","pages":"397-8"},"PeriodicalIF":0.0,"publicationDate":"2002-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/00132580-200211000-00010","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22120458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pericardial disease in the oncology patient. 肿瘤患者的心包疾病。
Heart disease (Hagerstown, Md.) Pub Date : 2002-11-01 DOI: 10.1097/00132580-200211000-00008
Avi S Retter
{"title":"Pericardial disease in the oncology patient.","authors":"Avi S Retter","doi":"10.1097/00132580-200211000-00008","DOIUrl":"https://doi.org/10.1097/00132580-200211000-00008","url":null,"abstract":"<p><p>Malignant pericardial disease is a serious and common problem seen in patients with cancer. It is usually due to metastatic spread of the underlying malignancy or a complication of radiation therapy. The patient may have a mild, subtle presentation, as is often seen in the early stages of pericardial effusion, or may experience dramatic hemodynamic compromise, as is seen with cardiac tamponade and constrictive pericarditis. There are many treatment options available that range from simple drainage to thoracic surgery. It is essential that the treating physician choose a treatment plan in the context of the cancer stage and the patient's prognosis. This article discusses the incidence, pathophysiology, clinical presentation, diagnosis, and treatment options in the various types of malignant pericardial disease.</p>","PeriodicalId":83724,"journal":{"name":"Heart disease (Hagerstown, Md.)","volume":"4 6","pages":"387-91"},"PeriodicalIF":0.0,"publicationDate":"2002-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/00132580-200211000-00008","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22119371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 22
An odyssey of a clinical researcher. 一个临床研究者的奥德赛。
Heart disease (Hagerstown, Md.) Pub Date : 2002-11-01 DOI: 10.1097/00132580-200211000-00009
William H Frishman
{"title":"An odyssey of a clinical researcher.","authors":"William H Frishman","doi":"10.1097/00132580-200211000-00009","DOIUrl":"https://doi.org/10.1097/00132580-200211000-00009","url":null,"abstract":"","PeriodicalId":83724,"journal":{"name":"Heart disease (Hagerstown, Md.)","volume":"4 6","pages":"392-6"},"PeriodicalIF":0.0,"publicationDate":"2002-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/00132580-200211000-00009","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22120457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiac arrest associated with intravenous propofol during transesophageal echocardiography before DC cardioversion. 心脏骤停与经食管超声心动图中静脉注射异丙酚有关。
Heart disease (Hagerstown, Md.) Pub Date : 2002-11-01 DOI: 10.1097/00132580-200211000-00004
Edmund A Bermudez, Ming Hui Chen
{"title":"Cardiac arrest associated with intravenous propofol during transesophageal echocardiography before DC cardioversion.","authors":"Edmund A Bermudez,&nbsp;Ming Hui Chen","doi":"10.1097/00132580-200211000-00004","DOIUrl":"https://doi.org/10.1097/00132580-200211000-00004","url":null,"abstract":"<p><p>Transesophageal echocardiography (TEE)-guided cardioversion has been utilized as a feasible alternative to conventional anticoagulation strategies in the management of patients with atrial fibrillation. As such, the use of intravenous sedation protocols using relatively short-acting anesthetics, such as propofol, have gained popularity in the outpatient and inpatient settings for such procedures. The authors report a case of cardiac arrest and electromechanical dissociation associated with the use of intravenous propofol during TEE before direct current cardioversion for atrial fibrillation.</p>","PeriodicalId":83724,"journal":{"name":"Heart disease (Hagerstown, Md.)","volume":"4 6","pages":"355-7"},"PeriodicalIF":0.0,"publicationDate":"2002-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/00132580-200211000-00004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22119369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Influenza A and B IgG seropositivity and coronary atherosclerosis assessed by angiography. 血管造影评估流感A、B IgG血清阳性与冠状动脉粥样硬化的关系。
Heart disease (Hagerstown, Md.) Pub Date : 2002-11-01 DOI: 10.1097/00132580-200211000-00003
Johann Auer, Markus Leitinger, Robert Berent, Wolfgang Prammer, Thomas Weber, Elisabeth Lassnig, Bernd Eber
{"title":"Influenza A and B IgG seropositivity and coronary atherosclerosis assessed by angiography.","authors":"Johann Auer,&nbsp;Markus Leitinger,&nbsp;Robert Berent,&nbsp;Wolfgang Prammer,&nbsp;Thomas Weber,&nbsp;Elisabeth Lassnig,&nbsp;Bernd Eber","doi":"10.1097/00132580-200211000-00003","DOIUrl":"https://doi.org/10.1097/00132580-200211000-00003","url":null,"abstract":"<p><p>Infectious agents, in particular intracellular pathogens that can establish long-term, persistent seropositivity, may play an important role in atherogenesis. The possible association between influenza type A and B infection and angiographically proven coronary artery disease (CAD) and the effect of the aggregate pathogen burden on CAD was studied by testing blood from 218 patients undergoing coronary angiography for serum IgG antibodies to influenza A and B, and for antibodies to four other pathogens (hepatitis A, Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus). This analysis demonstrates that although influenza (A and B) seropositivity represents no predictor of risk for CAD, infectious burden is independently associated with coronary atherosclerosis.</p>","PeriodicalId":83724,"journal":{"name":"Heart disease (Hagerstown, Md.)","volume":"4 6","pages":"349-54"},"PeriodicalIF":0.0,"publicationDate":"2002-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/00132580-200211000-00003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22119366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
Comprehensive management of hypertensive emergencies and urgencies. 高血压急症和急症的综合管理。
Heart disease (Hagerstown, Md.) Pub Date : 2002-11-01 DOI: 10.1097/00132580-200211000-00005
George A Mansoor, William H Frishman
{"title":"Comprehensive management of hypertensive emergencies and urgencies.","authors":"George A Mansoor,&nbsp;William H Frishman","doi":"10.1097/00132580-200211000-00005","DOIUrl":"https://doi.org/10.1097/00132580-200211000-00005","url":null,"abstract":"<p><p>Despite advances in chronic hypertension management, hypertensive emergencies and urgencies remain as serious complications. Much of this relates to poor compliance with effective antihypertensive management. Hypertensive emergencies and urgencies can also be seen as the initial manifestations of hypertension in pregnancy and in the perioperative period. Multiple classes of intravenous antihypertensive drugs are available to treat hypertensive emergencies, and specific agents may have an advantage in a given clinical situation. Orally active agents are used to treat hypertensive urgencies, and include clonidine, angiotensin-converting enzyme inhibitors, and labetalol. Most patients respond to drug therapy, but problems may arise related to a rapid normalization of blood pressure.</p>","PeriodicalId":83724,"journal":{"name":"Heart disease (Hagerstown, Md.)","volume":"4 6","pages":"358-71"},"PeriodicalIF":0.0,"publicationDate":"2002-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/00132580-200211000-00005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22119367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 35
New drugs for treating lipid abnormalities. 治疗血脂异常的新药。
Heart disease (Hagerstown, Md.) Pub Date : 2002-11-01 DOI: 10.1097/00132580-200211000-00001
William H Frishman
{"title":"New drugs for treating lipid abnormalities.","authors":"William H Frishman","doi":"10.1097/00132580-200211000-00001","DOIUrl":"https://doi.org/10.1097/00132580-200211000-00001","url":null,"abstract":"","PeriodicalId":83724,"journal":{"name":"Heart disease (Hagerstown, Md.)","volume":"4 6","pages":"343"},"PeriodicalIF":0.0,"publicationDate":"2002-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/00132580-200211000-00001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22119364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书